Eli Lilly Files 8-K on Shareholder Vote Matters
Ticker: LLY · Form: 8-K · Filed: May 9, 2024 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | 8-K |
| Filed Date | May 9, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, shareholder-vote
Related Tickers: LLY
TL;DR
LLY filed an 8-K for shareholder vote matters - expect updates on governance.
AI Summary
Eli Lilly and Company (LLY) filed an 8-K on May 9, 2024, to report the submission of matters to a vote of security holders. This filing indicates that the company is preparing for or has held a shareholder meeting where important company decisions are being voted upon. Specific details regarding the proposals or outcomes of the vote were not included in this particular filing, but it serves as a formal notification to the SEC and investors.
Why It Matters
This filing signals that Eli Lilly is engaging in corporate governance processes, which can impact shareholder rights and company direction.
Risk Assessment
Risk Level: low — This filing is a procedural notification and does not contain new financial or operational risks.
Key Players & Entities
- Eli Lilly & Co (company) — Filer
- 0000059478-24-000127 (filing_id) — Accession Number
- 20240509 (date) — Filing Date
FAQ
What specific matters were submitted for a vote of security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were presented.
When did the submission of matters to a vote of security holders occur?
The filing was made as of May 9, 2024, and the period of report was May 6, 2024, indicating the matters were submitted around this time.
Is this filing related to a specific event like an acquisition or earnings release?
No, this 8-K filing specifically pertains to the 'Submission of Matters to a Vote of Security Holders' and not other typical 8-K event types.
Does this filing provide details on the outcome of the shareholder vote?
No, this filing serves as notification of the submission of matters to a vote, not the results or outcomes of that vote.
What is the SEC Act under which this report is filed?
This report is filed pursuant to the 1934 Act.
Filing Stats: 884 words · 4 min read · ~3 pages · Grade level 12.7 · Accepted 2024-05-09 16:34:08
Filing Documents
- lly-20240506.htm (8-K) — 73KB
- 0000059478-24-000127.txt ( ) — 294KB
- lly-20240506.xsd (EX-101.SCH) — 4KB
- lly-20240506_def.xml (EX-101.DEF) — 20KB
- lly-20240506_lab.xml (EX-101.LAB) — 38KB
- lly-20240506_pre.xml (EX-101.PRE) — 21KB
- lly-20240506_htm.xml (XML) — 10KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. The Eli Lilly and Company (the "Company") annual meeting of shareholders (the "2024 Annual Meeting") was held on May 6, 2024. The total number of shares of the Company's common stock voted in person or by proxy at the 2024 Annual Meeting was 856,671,228, representing approximately 90% of the 950,766,100 shares that were outstanding and entitled to vote as of February 28, 2024, the record date of the 2024 Annual Meeting. Voting results for each matter submitted to a vote at the 2024 Annual Meeting are provided below. a) The four nominees for director were elected to serve three-year terms ending at the Company's annual meeting of shareholders in 2027, as follows: Nominee For Against Abstain Broker Nonvote Katherine Baicker, Ph.D. 768,750,015 4,790,679 874,425 82,256,109 J. Erik Fyrwald 707,022,149 66,489,475 903,495 82,256,109 Jamere Jackson 756,573,062 16,842,872 999,185 82,256,109 Gabrielle Sulzberger 758,868,317 14,553,438 993,364 82,256,109 b) By the following vote, the shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers: For Against Abstain Broker Nonvote 734,022,954 38,576,757 1,815,408 82,256,109 c) The appointment of Ernst & Young LLP as the Company's independent auditor for 2024 was ratified by the following shareholder vote: For Against Abstain 819,656,263 35,914,315 1,100,650 d) The proposal to amend the Company's Articles of Incorporation (the "Articles") to eliminate the classified board structure did not receive the required vote of 80% of outstanding shares. The shareholders voted as follows: For Against Abstain Broker Nonvote 666,456,836 106,518,999 1,439,284 82,256,109 e) The proposal to amend the Articles to eliminate supermajority voting provisions did not receive the required vote of 80% of outstanding shares. The shareholders voted as follows: For Against Abstain Broker Nonvote 665,237,870 108,058,
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ELI LILLY AND COMPANY (Registrant) By: /s/ Anat Hakim Name: Anat Hakim Title: Executive Vice President, General Counsel and Secretary Date: May 9, 2024